Commit Biologics ApS Financials, key figures and credit report
Gross profit -23 365.2 kDKK FY 2025 +25.6% vs 2024
EBIT -39 469.3 kDKK FY 2025 +13.2% vs 2024
Net debt -30 390.3 kDKK FY 2025 -85.2% vs 2024
Quick ratio 40.1 FY 2025 +21.9 vs 2024
Income statement (kDKK)
2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 |
| Net sales | ||||
| Gross profit | -2 722.31 | -13 580.25 | -31 408.01 | -23 365.25 |
| Employee benefit expenses | -1 725.22 | -7 083.65 | -13 863.75 | -15 848.56 |
| Total depreciation | - 111.29 | - 205.06 | - 255.53 | |
| EBIT | -4 447.52 | -20 775.19 | -45 476.82 | -39 469.33 |
| Other financial income | 1.57 | 259.69 | 641.64 | 204.61 |
| Other financial expenses | - 186.75 | -15.23 | -25.60 | -16.36 |
| Pre-tax profit | -4 632.70 | -20 530.72 | -44 860.77 | -39 281.08 |
| Income taxes | 316.83 | 3 234.90 | 5 500.00 | 5 500.00 |
| Net earnings | -4 315.87 | -17 295.81 | -39 360.77 | -33 781.08 |
Assets (kDKK)
2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Intangible assets total | ||||
| Machinery and equipment | 1 522.11 | 2 008.76 | 2 282.66 | |
| Tangible assets total | 1 522.11 | 2 008.76 | 2 282.66 | |
| Investments total | 56.26 | |||
| Long term receivables total | ||||
| Inventories total | ||||
| Current owed by particip. interest comp. | 40.90 | 42.54 | 45.74 | |
| Prepayments and accrued income | 59.12 | |||
| Current other receivables | 40 441.08 | 266.74 | 487.69 | 519.53 |
| Current deferred tax assets | 316.83 | 3 234.90 | 5 500.00 | 5 500.00 |
| Short term receivables total | 40 798.82 | 3 544.18 | 6 033.43 | 6 078.65 |
| Cash and bank deposits | 213.98 | 18 259.71 | 16 409.03 | 30 390.35 |
| Cash and cash equivalents | 213.98 | 18 259.71 | 16 409.03 | 30 390.35 |
| Balance sheet total (assets) | 41 012.79 | 23 326.00 | 24 451.21 | 38 807.92 |
Equity and liabilities (kDKK)
2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Share capital | 87.97 | 87.97 | 130.98 | 177.41 |
| Other reserves | 40 000.00 | |||
| Retained earnings | 4 102.51 | 39 786.64 | 62 447.81 | 71 501.69 |
| Profit of the financial year | -4 315.87 | -17 295.81 | -39 360.77 | -33 781.08 |
| Shareholders equity total | 39 874.61 | 22 578.79 | 23 218.02 | 37 898.03 |
| Non-current liabilities total | ||||
| Current trade creditors | 998.55 | 284.20 | 626.96 | 892.96 |
| Other non-interest bearing current liabilities | 139.64 | 463.00 | 606.24 | 16.93 |
| Current liabilities total | 1 138.19 | 747.20 | 1 233.19 | 909.89 |
| Balance sheet total (liabilities) | 41 012.79 | 23 326.00 | 24 451.21 | 38 807.92 |
Secure checkout
Buy AI Credit Risk Report
Pay by card and the report is generated automatically and sent to your email. One-time payment – no subscription.
How it works
- 01 You pay €3 (incl. VAT) securely by card via Stripe.
- 02 You enter your email address in Stripe's payment window – the report is sent there.
- 03 The report is generated automatically and sent as a PDF within 30 minutes.
- 04 If generation should fail, you are not charged.
- 05 You receive the receipt by email once the report has been generated and completed.
Do you want to buy the AI Credit Risk Report (3 EUR / report)?
The report is sent to the email address you enter in Stripe's payment window. Please also check your spam folder. Questions? Write to info@creditreports.dk.
Page generated